Analysis of systemic endothelin-1, matrix metalloproteinase-9, macrophage chemoattractant protein-1, and high-sensitivity C-reactive protein in normal-tension glaucoma

Current Eye Research

Volumn 37, Issue 12, 2012, Pages 1121-1126

  Young Lee, Na ^a,b   Park, Hae Young Lopilly ^a,c   Park, Chan Kee ^a,c   Ahn, Myung Douk ^a,c  

^a The Catholic University of Korea   (South Korea)

^b The Catholic University of Korea   (South Korea)

^c The Catholic University of Korea   (South Korea)

Author keywords

Endothelin 1; High sensitivity C reactive protein; Macrophage chemoattractant protein 1; Matrix metalloproteinase 9; Normal tension glaucoma

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; ENDOTHELIN 1; GELATINASE B; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ERYTHROCYTE COUNT; FEMALE; HEMATOCRIT; HUMAN; INFLAMMATION; LEUKOCYTE COUNT; LOW TENSION GLAUCOMA; MALE; PRIORITY JOURNAL; PROTEIN ANALYSIS; THROMBOCYTE COUNT; VASCULAR DISEASE;

C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CHEMOKINE CCL2; ENDOTHELIN-1; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INFLAMMATION; INTRAOCULAR PRESSURE; ISCHEMIA; LOW TENSION GLAUCOMA; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 84870286898     PISSN: 02713683     EISSN: 14602202     Source Type: Journal    
DOI: 10.3109/02713683.2012.725798     Document Type: Article

References (39)

1. Van Buskirk EM, Cioff GA. Glaucomatous optic neuropathy. Am J Ophthalmol 1992;113:447-452.
2. Allingham RR, Damji KF, Freedman S et al. Shields textbook of glaucoma. 6th edition. Philadelphia: LWW; 2011. pp xiii.
3. Drance SM, Sweeney VP, Morgan RW et al. Studies of factors involved in the production of low tension glaucoma. Arch Ophthalmol 1973;89:457-465.
4. Gasser P. Ocular vasospasm: a risk factor in the pathogenesis of low-tension glaucoma. Int Ophthalmol 1989;13:281-290. (Pubitemid 20016660)
5. Rojanapongpun P, Drance SM. The response of blood fow velocity in the ophthalmic artery and blood fow of the fnger to warm and cold stimuli in glaucomatous patients. Graefes Arch Clin Exp Ophthalmol 1993;231:375-377. (Pubitemid 23258532)
6. Kim CS, Seong GJ, Lee NH et al Namil Study Group, Korean Glaucoma Society. Prevalence of primary open-angle glaucoma in central South Korea the Namil study. Ophthalmology 2011;118:1024-1030.
7. Sugiyama T, Moriya S, Oku H et al. Association of endothe-lin-1 with normal tension glaucoma: clinical and fundamental studies. Surv Ophthalmol 1995;39 Suppl 1:S49-S56.
8. Henry E, Newby DE, Webb DJ et al. Altered endothelin-1 vasoreactivity in patients with untreated normal-pressure glaucoma. Invest Ophthalmol Vis Sci 2006;47:2528-2532. (Pubitemid 351639837)
9. Conti P, DiGioacchino M. MCP-1 and RANTES are mediators of acute and chronic infammation. Allergy Asthma Proc 2001;22:133-137.
10. Koyama Y, Baba A, Matsuda T. Production of monocyte chemoattractant protein-1 and cytokine-induced neutrophil chemoattractant-1 in rat brain is stimulated by intracerebro-ventricular administration of an endothelin ETB receptor agonist. Neuroreport 2007;18:1275-1279. (Pubitemid 47075596)
11. Shin WS, Szuba A, Rockson SG. The role of chemokines in human cardiovascular pathology: enhanced biological insights. Atherosclerosis 2002;160:91-102. (Pubitemid 34076646)
12. Taylor PC, Peters AM, Paleolog E et al. Reduction of chemo-kine levels and leukocyte traffc to joints by tumor necrosis factor alpha blockade in patients with rheumatoid arthritis. Arthritis Rheum 2000;43:38-47. (Pubitemid 30368211)
13. O'Hayre M, Salanga CL, Handel TM et al. Chemokines and cancer: migration, intracellular signalling and intercellular communication in the microenvironment. Biochem J 2008;409:635-649. (Pubitemid 351214190)
14. Gourmala NG, Buttini M, Limonta S et al. Differential and time-dependent expression of monocyte chemoattractant pro-tein-1 mRNA by astrocytes and macrophages in rat brain: effects of ischemia and peripheral lipopolysaccharide administration. J Neuroimmunol 1997;74:35-44. (Pubitemid 27128975)
15. Pasceri V, Willerson JT, Yeh ET. Direct proinfammatory effect of C-reactive protein on human endothelial cells. Circulation 2000;102:2165-2168.
16. Leibovitch I, Kurtz S, Kesler A et al. C-reactive protein levels in normal tension glaucoma. J Glaucoma 2005;14:384-386. (Pubitemid 41383332)
17. Su WW, Ho WJ, Cheng ST et al. Systemic high-sensitivity C-reactive protein levels in normal-tension glaucoma and primary open-angle glaucoma. J Glaucoma 2007;16:320-323.
18. de Voogd S, Wolfs RC, Jansonius NM et al. Atherosclerosis, C-reactive protein, and risk for open-angle glaucoma: the Rotterdam study. Invest Ophthalmol Vis Sci 2006;47:3772-3776. (Pubitemid 46044289)
19. Mozaffarieh M, Flammer J. Is there more to glaucoma treatment than lowering IOP? Surv Ophthalmol 2007;52 Suppl 2:S174-S179. (Pubitemid 350060969)
20. Agapova OA, Ricard CS, Salvador-Silva M et al. Expression of matrix metalloproteinases and tissue inhibitors of metal-loproteinases in human optic nerve head astrocytes. Glia 2001;33:205-216. (Pubitemid 32219129)
21. Golubnitschaja O, Yeghiazaryan K, Liu R et al. Increased expression of matrix metalloproteinases in mononuclear blood cells of normal-tension glaucoma patients. J Glaucoma 2004;13:66-72. (Pubitemid 38112357)
22. Good TJ, Kahook MY. The role of endothelin in the pathophys-iology of glaucoma. Expert Opin Ther Targets 2010;14:647-654.
23. Shields MB. Normal-tension glaucoma: is it different from primary open-angle glaucoma? Curr Opin Ophthalmol 2008;19:85-88. (Pubitemid 351322808)
24. Chen HY, Chang YC, Chen WC et al. Association between plasma endothelin-1 and severity of different types of glaucoma. J Glaucoma 2011;Sep 22.
25. Grieshaber MC, Flammer J. Does the blood-brain barrier play a role in Glaucoma? Surv Ophthalmol 2007;52 Suppl 2:S115-S121. (Pubitemid 350060961)
26. Nicolela MT, Ferrier SN, Morrison CA et al. Effects of cold-induced vasospasm in glaucoma: the role of endothelin-1. Invest Ophthalmol Vis Sci 2003;44:2565-2572. (Pubitemid 36618416)
27. Resch H, Garhofer G, Fuchsjäger-Mayrl G et al. Endothelial dysfunction in glaucoma. Acta Ophthalmol 2009;87:4-12.
28. Kunimatsu S, Mayama C, Tomidokoro A et al. Plasma endo-thelin-1 level in Japanese normal tension glaucoma patients. Curr Eye Res 2006;31:727-731. (Pubitemid 44373544)
29. Kaiser HJ, Flammer J, Wenk M et al. Endothelin-1 plasma levels in normal-tension glaucoma: abnormal response to postural changes. Graefes Arch Clin Exp Ophthalmol 1995;233:484-488.
30. Chen P, Shibata M, Zidovetzki R et al. Endothelin-1 and monocyte chemoattractant protein-1 modulation in ischemia and human brain-derived endothelial cell cultures. J Neuroimmunol 2001;116:62-73. (Pubitemid 32322640)
31. Nagasawa H, Kogure K. Correlation between cerebral blood fow and histologic changes in a new rat model of middle cerebral artery occlusion. Stroke 1989;20:1037-1043. (Pubitemid 19204017)
32. Kochanek PM, Hallenbeck JM. Polymorphonuclear leukocytes and monocytes/macrophages in the pathogenesis of cerebral ischemia and stroke. Stroke 1992;23:1367-1379.
33. Pepys MB, Berger A. The renaissance of C reactive protein. BMJ 2001;322:4-5. (Pubitemid 32066246)
34. Kirwan RP, Crean JK, Fenerty CH et al. Effect of cyclical mechanical stretch and exogenous transforming growth factor-beta1 on matrix metalloproteinase-2 activity in lamina cribrosa cells from the human optic nerve head. J Glaucoma 2004;13:327-334. (Pubitemid 38944202)
35. Grieshaber MC, Terhorst T, Flammer J. The pathogenesis of optic disc splinter haemorrhages: a new hypothesis. Acta Ophthalmol Scand 2006;84:62-68. (Pubitemid 43347997)
36. Flammer J, Mozaffarieh M. What is the present pathogenetic concept of glaucomatous optic neuropathy? Surv Ophthalmol 2007;52 Suppl 2:S162-S173. (Pubitemid 350060968)
37. Chintala SK, Zhang X, Austin JS et al. Defciency in matrix metalloproteinase gelatinase B (MMP-9) protects against retinal ganglion cell death after optic nerve ligation. J Biol Chem 2002;277:47461-47468. (Pubitemid 36159263)
38. He S, Prasanna G, Yorio T. Endothelin-1-mediated signaling in the expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in astrocytes. Invest Ophthalmol Vis Sci 2007;48:3737-3745. (Pubitemid 351261112)
39. Collaborative NTG Study Group. Comparison of glaucoma-tous progression between untreated patients with NTG and patients with therapeutically reduced IOP. Am J Ophthalmol 1998;126:487-497.